>
4Front Ventures logo

FFNT - 4Front Ventures Share Price

C$1.46 0.0  0.0%

Last Trade - 3:54pm

Sector
Consumer Defensives
Size
Mid Cap
Market Cap £907.2m
Enterprise Value £981.1m
Revenue £41.9m
Position in Universe 234th / 2712
Bullish
Bearish
Unlock FFNT Revenue
Momentum
Relative Strength (%)
1m -17.2%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -42.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.72 3.77 31.1 57.6 161 +330.8%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, 4FrontVentures Corp revenues increased 85% to $57.6M. Net lossbefore extraordinary items decreased 67% to $60M. Revenuesreflect an increase in demand for the Company's productsand services due to favorable market conditions. Lower netloss reflects Equity based compensation decrease of 10% to$5.3M (expense), Depreciation and amortization decrease of2% to $4.1M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

FFNT Revenue Unlock FFNT Revenue

Net Income

FFNT Net Income Unlock FFNT Revenue

Normalised EPS

FFNT Normalised EPS Unlock FFNT Revenue

PE Ratio Range

FFNT PE Ratio Range Unlock FFNT Revenue

Dividend Yield Range

FFNT Dividend Yield Range Unlock FFNT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
FFNT EPS Forecasts Unlock FFNT Revenue
Profile Summary

4Front Ventures Corp operates licensed cannabis facilities in state-licensed markets in the United States. The Company manufactures and distributes a portfolio of over 25 cannabis brands, including Marmas, Crystal Clear, Funky Monkey, Pebbles, and the Pure Ratios wellness collection. Its segments include Retail, Production, Pure Ratios and Real Estate. The Retail segment includes the Company's controlled cannabis dispensaries and management and consulting fees for assisting third party dispensaries. The Production segment is engaged in the production of cannabis products and the importing of equipment and supplies for resale. The Pure Ratios segment is engaged in the production and sale of cannabidiol (CBD) products. The Real Estate segment is focused on leasing of cannabis production facilities in the state of Washington. The Company has operations in Illinois, Massachusetts, California, Michigan, and Washington state.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated July 31, 2019
Public Since December 5, 2006
No. of Shareholders: n/a
No. of Employees: n/a
Sector Consumer Defensives
Industry Food & Drug Retailing
Index
Exchange Canadian Securities Exchange
Shares in Issue 1,070,497,617
Free Float (0.0%)
Eligible for
ISAs
SIPPs
FFNT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for FFNT
Upcoming Events for FFNT
Tuesday 20th April, 2021
4Front Ventures Corp at NA Of Investors KCSA Cannabis Conference
Frequently Asked Questions for 4Front Ventures
What is the 4Front Ventures share price?

As of 3:54pm, shares in 4Front Ventures are trading at C$1.46, giving the company a market capitalisation of £907.2m. This share price information is delayed by 15 minutes.

How has the 4Front Ventures share price performed this year?

Shares in 4Front Ventures are currently trading at C$1.46 and the price has moved by 0.317k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the 4Front Ventures price has moved by 0.210k% over the past year.

What are the analyst and broker recommendations for 4Front Ventures?

Of the analysts with advisory recommendations for 4Front Ventures, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for 4Front Ventures is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will 4Front Ventures next release its financial results?

4Front Ventures is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the 4Front Ventures dividend yield?

4Front Ventures does not currently pay a dividend.

Does 4Front Ventures pay a dividend?

4Front Ventures does not currently pay a dividend.

When does 4Front Ventures next pay dividends?

4Front Ventures does not currently pay a dividend.

How do I buy 4Front Ventures shares?

To buy shares in 4Front Ventures you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of 4Front Ventures?

Shares in 4Front Ventures are currently trading at C$1.46, giving the company a market capitalisation of £907.2m.

Where are 4Front Ventures shares listed? Where are 4Front Ventures shares listed?

Here are the trading details for 4Front Ventures:

Country of listing: Canada
Exchange: CNX
Ticker Symbol: FFNT
What kind of share is 4Front Ventures?

Based on an overall assessment of its quality, value and momentum, 4Front Ventures is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a 4Front Ventures share price forecast 2021?

Shares in 4Front Ventures are currently priced at C$1.46. At that level they are trading at 26.03% premium to the analyst consensus target price of 0.00.

Analysts covering 4Front Ventures currently have a consensus Earnings Per Share (EPS) forecast of 0.0364412258 for the next financial year.

How can I tell whether the 4Front Ventures share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 4Front Ventures. Over the past six months, the relative strength of its shares against the market has been 47.05%. At the current price of C$1.46, shares in 4Front Ventures are trading at 28.63% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the 4Front Ventures PE Ratio?

We were not able to find PE ratio data for 4Front Ventures.

Who are the key directors of 4Front Ventures?

We were unable to find the directors for 4Front Ventures.

Who are the major shareholders of 4Front Ventures?

Here are the top five shareholders of 4Front Ventures based on the size of their shareholding:

Gontmakher (Leonid) Individual Investor
Percentage owned: 5.35% (30.3m shares)
Chowscano (Karl Anthony) Individual Investor
Percentage owned: 4.44% (25.1m shares)
Rosen (Joshua Nathaniel) Individual Investor
Percentage owned: 4.18% (23.7m shares)
Putnam Global Health Care Fund Mutual Fund
Percentage owned: 2.78% (15.8m shares)
Tkachenko (Roman Igorevich) Individual Investor
Percentage owned: 2.51% (14.2m shares)
Similar to FFNT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.